ClinConnect ClinConnect Logo
Search / Trial NCT06488326

Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteers

Launched by CHULALONGKORN UNIVERSITY · Jun 28, 2024

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of mulberry leaf extract on blood sugar levels in healthy volunteers. Participants will be divided into four groups: one group will receive a 6 mg capsule, another a 12 mg capsule, a third an 18 mg capsule, and the last group will receive a placebo, which is a capsule that contains no active ingredients. Before taking the capsule, participants will have their blood sugar levels checked. After taking the capsule, they will drink a sugary solution, and their blood sugar will be tested again at several points over the next two hours to see how the mulberry leaf extract affects their blood sugar response.

To be eligible for this study, participants must be between 18 and 60 years old, not have diabetes, and have normal blood sugar levels below 126 mg/dL. They also need to be willing to attend the study sessions. However, people who are currently taking certain medications, have uncontrolled health issues, or have had specific surgeries will not be able to participate. This trial is currently not recruiting participants, but it aims to understand how a natural supplement like mulberry leaf extract might help with blood sugar control in healthy individuals.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-60 years
  • No diabetes mellitus
  • Have blood glucose less than 126 mg/dL
  • Wiling to attend the study
  • Exclusion Criteria:
  • Take steroids, psychiatric medicine, thiazide diuretic medicine, and beta blocker medicine within 2 weeks before starting of the study
  • Take dietary supplement, herbal substance, and weight-loss medicine within 2 weeks before starting of the study
  • Uncontrolled diseases
  • History of gastrointestinal tract surgery
  • Liver and Kidney diseases
  • Pregnancy and lactation

About Chulalongkorn University

Chulalongkorn University, one of Thailand's premier academic institutions, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous scientific investigations. Chulalongkorn University aims to contribute to global health advancements by fostering a culture of excellence in research, education, and community service, ultimately improving patient care and public health standards.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported